Dalian Bio-Chem Co Ltd
Dalian BIO-CHEM Company Limited researches, develops, produces, and sells industrial fungicides in China and internationally. It offers various isothiazolinone fungicides, including CMIT/MIT, MIT, OIT, DCOIT, and BIT series products; and OEM/ODM services. The company was founded in 2003 and is headquartered in Dalian, China.
Dalian Bio-Chem Co Ltd (603360) - Total Liabilities
Latest total liabilities as of September 2025: CN¥1.58 Billion CNY
Based on the latest financial reports, Dalian Bio-Chem Co Ltd (603360) has total liabilities worth CN¥1.58 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Dalian Bio-Chem Co Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how Dalian Bio-Chem Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Dalian Bio-Chem Co Ltd Competitors by Total Liabilities
The table below lists competitors of Dalian Bio-Chem Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
JiShi Media Co Ltd
SHG:601929
|
China | CN¥7.61 Billion |
|
Grupo Bafar S.A.B. de C.V
MX:BAFARB
|
Mexico | MX$16.53 Billion |
|
G-III Apparel Group Ltd
NASDAQ:GIII
|
USA | $969.59 Million |
|
Harbin Boshi Automation Co Ltd
SHE:002698
|
China | CN¥2.63 Billion |
|
Fusheng Precision Co Ltd
TW:6670
|
Taiwan | NT$8.78 Billion |
|
CRA International Inc
NASDAQ:CRAI
|
USA | $415.27 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down Dalian Bio-Chem Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.96 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Dalian Bio-Chem Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Dalian Bio-Chem Co Ltd (2011–2024)
The table below shows the annual total liabilities of Dalian Bio-Chem Co Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.29 Billion | +322.50% |
| 2023-12-31 | CN¥304.99 Million | +4.05% |
| 2022-12-31 | CN¥293.12 Million | -52.80% |
| 2021-12-31 | CN¥621.07 Million | +40.70% |
| 2020-12-31 | CN¥441.41 Million | +183.27% |
| 2019-12-31 | CN¥155.83 Million | +56.85% |
| 2018-12-31 | CN¥99.35 Million | +6.93% |
| 2017-12-31 | CN¥92.91 Million | -44.79% |
| 2016-12-31 | CN¥168.28 Million | -10.53% |
| 2015-12-31 | CN¥188.08 Million | -28.17% |
| 2014-12-31 | CN¥261.83 Million | -2.89% |
| 2013-12-31 | CN¥269.63 Million | +1.64% |
| 2012-12-31 | CN¥265.28 Million | -3.66% |
| 2011-12-31 | CN¥275.35 Million | -- |